Perspectives
Drug Pipeline Update: October 2021
New drugs, new indications and news of note.
October 28, 2021This monthly pipeline wrap up provides a review of newly approved drugs, recent drug launches, generic updates, new indications and news of note on drugs in the approval process.
Related news
Perspectives
April 17, 2024
AMCP 2024: Behind the research with YuQian Liu
Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of this exciting frontier
Perspectives
April 16, 2024
AMCP 2024: Behind the research with Jacob LaRue and Timothy O’Shea
Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty drugs without therapeutic impact to patients
Perspectives
April 15, 2024
Oncology Insights: Cancer treatment is personal
Precision medicine, or personalized medicine, uses genes or proteins to diagnose or treat disease. This medical care design has significantly impacted oncology and grew out of a need to improve and individualize patient treatments